Bikini moguls Natasha Oakley and Devin Brugman made the most of the Caribbean sun this week. The Monday Swimwear founders were spotted catching some rays and showing off their beach-ready bodies ...

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. The newsletter was supposed to be on ...

Sutro Biopharma is cutting 65 jobs across two Bay Area locations. The layoffs, which are permanent according to state filings, will see three people lose their jobs at Sutro’s South San ...

H.C. Wainwright downgraded Sutro Biopharma (STRO) to Neutral from Buy with a price target of $2, down from $12, after the company announced a strategic realignment focused on advancing its next ...

FAYETTEVILLE, Ark. — After her team’s doubleheader sweep of Arkansas on Saturday, OU softball coach Patty Gasso praised her team’s “relentless” approach offensively. The top-ranked Sooners showed that ...

The late-breaking oral presentation at SGO 2025 highlights consistent response rates observed in patients across all levels of FRα expression of 25% or greater – SOUTH SAN FRANCISCO, CA, USA I March ...

On Friday, Oppenheimer analysts downgraded Sutro Biopharma (NASDAQ:STRO) stock from Outperform to Perform, following the company’s announcement of its fourth-quarter 2024 financial results and ...

Sutro Bio­phar­ma is re­duc­ing its head­count by 50%, ap­point­ing a new CEO, shut­ting down its on­ly fac­to­ry, and shift­ing away from its lead can­di­date. … ...

Sutro Biopharma’s 2024 revenue fell to $62 million from $153.7 million in 2023. The company expects its cash runway to last through at least Q4 2026, excluding potential milestone payments. Feel ...

Sutro Biopharma Inc (NASDAQ:STRO) has prioritized three wholly owned pre-clinical programs in its next-generation ADC pipeline, indicating a focused strategic direction. The company's cash runway ...

Sutro Biopharma is undergoing a seismic shake-up—jettisoning its CEO, half of its workforce, its lead candidate and its manufacturing facility in a major bid to save cash. The almost 50% layoffs ...

Sutro Biopharma, a South San Francisco company working to design anti-cancer drugs, is a fresh face for biotech’s extreme risk — and its fallout. As of this year, the company had racked up ...